Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATTERHORN: Roxadustat for Anemia in Lower Risk MDS
NCT03263091Phase 3Terminated
- Sponsor
- FibroGen
- Start
- Jan 2018
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of roxadustat in anemia, sponsored by FibroGen. Started Jan 2018; status: terminated.
02
Drugs
roxadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03263091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03263091.